It is important to note that previous studies evaluating the role of IL-22 in mediating metabolic disorders have relied solely on the use of global knockouts of the cytokine or its receptor or systemic treatment and/or depletion of IL-22. The gene discussed is IL22; the disease is Other metabolic disease.